MIR373 is a microRNA that has been predicted by computational algorithms to regulate several proteins involved in the actin cytoskeleton, including twinfilin-1 and-2, thymosin, and profilin-2 [PMC7408560]. In a study evaluating breast cancer biomarkers, MIR373 was selected as a candidate and its expression levels were assessed in breast cancer patients and healthy individuals [PMC8182592]. Another study found that MIR373 was involved in a subpopulation of chemo-resistant circulating tumor cells (CTCs) with extensive aberrations and marked metastatic ability [PMC8466266]. Additionally, MIR373 levels were found to be upregulated in the substantia nigra of patients with Parkinson's disease, suggesting its involvement in α-synuclein clearance defects [PMC6627933]. These findings highlight the potential role of MIR373 as a regulator of actin cytoskeleton proteins, a biomarker for breast cancer, chemo-resistant CTCs, and Parkinson's disease pathology.
- G uuuuug gggauACUC AAAAU GGGGCGCUUUCC u ||||||||| ||||| |||||||||||| cccUGUGGG UUUUA CUUCGUGAAGgg c G G ucaugu
Name | Accession | Chromosome | Start | End | Strand | Confidence |
---|
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0000725 |
Description | Homo sapiens hsa-miR-373-5p mature miRNA |
Sequence | 6 - ACUCAAAAUGGGGGCGCUUUCC - 27 |
Evidence |
experimental
cloned [1] |
Accession | MIMAT0000726 |
Description | Homo sapiens hsa-miR-373-3p mature miRNA |
Sequence | 44 - GAAGUGCUUCGAUUUUGGGGUGU - 66 |
Evidence |
experimental
cloned [1-2], Northern [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|